By R. Dewayne Book, MD — Chief Medical Officer, Advaita Integrated Medicine
Most people who end up in my office have already tried to get better. They’ve been on antidepressants — sometimes one, sometimes several. They’ve been compliant. They’ve given the medications time. And they’ve either seen minimal improvement or none. By the time they get to me, a lot of them have quietly accepted that this is just how things are going to be.
I want to be direct about something: that conclusion is premature.
What those patients are experiencing has a name — treatment-resistant depression — and it isn’t a sign that depression has won. It’s a sign that the treatment approach hasn’t yet matched the real problem.
Here’s what’s going on.
What Is Treatment-Resistant Depression?
Treatment-resistant depression is depression that has not responded adequately to at least two antidepressant medications tried at appropriate doses for an appropriate length of time. It is not a rare edge case. Roughly one in three people with major depression will not respond adequately to medication. And with each additional medication that fails, the likelihood that the next one will produce a meaningful response gets smaller, not larger.
By the time a patient has tried five or six antidepressants without relief, the odds that a seventh will be the answer are very low. That’s not a reason to give up. It’s a reason to understand why medication hasn’t worked — and what else is available.
How Common Is Treatment-Resistant Depression?
Treatment-resistant depression affects approximately one in three people diagnosed with major depressive disorder. Research shows that after two failed medication trials, the likelihood of responding to a subsequent antidepressant drops significantly with each attempt. For a meaningful portion of people with depression, medication alone is not the complete answer — and continuing to cycle through antidepressants without exploring other options is unlikely to produce different results.
What Are the Signs That Antidepressants Aren’t Working?
There are clear clinical indicators that a medication trial has been inadequate. Signs that an antidepressant may not be working include:
- No meaningful improvement in mood, energy, or motivation after eight to twelve weeks at a therapeutic dose
- Partial improvement — feeling somewhat better but still far from functional — that has plateaued
- Improvement that fades after initial response
- Intolerable side effects that prevent staying on the medication long enough to assess its effectiveness
- Continued inability to function at work, in relationships, or in daily life despite being on medication
If any of these sound familiar, it doesn’t mean treatment has failed. It means the current approach needs to change.
Why Don’t Antidepressants Work for Everyone?
Antidepressants fail for a significant portion of patients because depression is not only a neurochemical illness — it is also a circuitry illness, and medication only addresses one of those two dimensions. Think of it this way. The neuron is the engine. The neurotransmitters — serotonin, dopamine, norepinephrine — are the fuel. If you have an engine that isn’t firing well, giving it higher quality fuel or more of it isn’t going to fix the problem. The engine itself is the issue.
For people with treatment-resistant depression, the prefrontal cortex — the region of the brain that regulates mood — is underactive. It isn’t firing the way it should. Adding more neurochemical availability to a circuit that’s already struggling to function doesn’t restore that circuit. It just increases the fuel supply to an engine that can’t use it.
This is why some people can be fully compliant with medication, do everything right, and still not get meaningfully better. The medication is addressing one dimension of the problem. The circuitry is another dimension entirely.
What Is Happening in the Brain During Treatment-Resistant Depression?
In treatment-resistant depression, the dorsolateral prefrontal cortex — the region primarily responsible for mood regulation — shows reduced activity, a state called hypoactivation. Antidepressants work by increasing the availability of neurotransmitters like serotonin and dopamine, but they don’t directly address the underlying circuitry dysfunction. When the neural pathways themselves aren’t firing effectively, increasing neurochemical availability has limited impact — which is why medication alone is insufficient for a significant portion of people with depression.
What Are the Treatment Options for Treatment-Resistant Depression?
When medication hasn’t worked, the most important shift is moving from a chemistry-based approach to one that addresses the circuitry directly. Treatment options for treatment-resistant depression include:
- Transcranial Magnetic Stimulation (TMS) — a non-invasive, FDA-approved treatment that uses targeted magnetic pulses to stimulate underactive areas of the prefrontal cortex directly
- Medication augmentation — adding a second medication to enhance the effect of an existing antidepressant, though response rates decrease with each additional trial
- Psychotherapy — particularly approaches like CBT and ACT, which address the behavioral and cognitive patterns that sustain depression
- Integrated treatment — combining TMS, therapy, and psychiatric oversight simultaneously, which research suggests produces stronger and more durable outcomes than any single approach alone
The most well-established option for addressing the circuitry directly is TMS. It doesn’t introduce any chemical into the body. It doesn’t affect the whole system the way medication does. It goes directly to the source of the problem and works on the circuitry itself.
The difference between how medication and TMS work isn’t subtle. Medication adjusts the fuel supply. TMS works on the engine.
Is TMS Effective for Treatment-Resistant Depression?
TMS is FDA-approved for treatment-resistant depression and has demonstrated meaningful clinical outcomes across multiple independent studies. For patients who have not responded to antidepressant medication, TMS offers a mechanism of action that medication cannot replicate — directly stimulating the neural circuitry rather than adjusting neurochemical availability.
At AIM, approximately 78% of patients who complete a full TMS course reach remission — a rate significantly above the national average of 30 to 35%.
When Should You Consider TMS for Depression?
TMS should be considered earlier in the treatment process than most patients or providers realize — the FDA approved it after a single antidepressant failure. Most insurance carriers require documentation of two or more failed medication trials before approving coverage, but the clinical case for considering TMS is strong from the moment a first medication produces an inadequate response.
Every additional antidepressant trial that fails isn’t just an ineffective treatment. It’s months of someone’s life spent in a depressive episode waiting for something that isn’t going to work. The sooner a provider considers alternatives, the sooner the patient has access to something that might.
If you’ve been on an antidepressant for an adequate trial — generally eight to twelve weeks at a therapeutic dose — and you’re not seeing a robust response, that’s the moment to start asking what else is available. Not after the third medication. Not after the fifth. After the first one that doesn’t work.
How Many Antidepressants Should You Try Before Considering TMS?
The FDA approved TMS after one antidepressant failure, making it a viable option much earlier in the treatment process than most patients or providers realize. Most insurance carriers require documentation of two or more failed medication trials for coverage approval. Clinically, a provider should begin considering alternatives to medication within two to three months of a patient showing an inadequate response — meaning either no meaningful improvement or improvement that falls short of remission.
What is the Effect of Treatment-Resistant Depression?
The real cost of treatment-resistant depression is not measured in medication copays — it is measured in the years of life spent below a baseline that didn’t have to be permanent. I see patients in their 60s and 70s who come to me after decades of living with depression — patients who tried medications that didn’t work and eventually stopped looking for something better. When TMS produces remission for these patients, the response is rarely simple relief. There’s often grief alongside it. Grief for the years spent severely depressed when other options existed.
Depression doesn’t just affect how you feel. It affects every decision you make, every relationship you’re in, every opportunity you pursue or don’t. Most people with depression are still showing up — going to work, maintaining their responsibilities — but doing it as a diminished version of themselves. Phoning it in. Going through the motions.
One of the things I notice most in patients before treatment is how they describe their life in the past tense. Things they used to enjoy. People they used to be close to. Plans they used to have. Depression narrows the world until survival feels like the only realistic goal. That’s not an acceptable baseline — and it doesn’t have to be permanent.
What to Do If You Think You Have Treatment-Resistant Depression
If antidepressants haven’t produced meaningful relief, the right next step is a thorough evaluation with a provider who understands the full range of options — not just the next medication on the list. At AIM, that evaluation looks at:
- Your complete medication history and how you responded to each trial
- Whether any comorbid conditions — anxiety, trauma, bipolar disorder, substance use — may be complicating treatment
- Which treatment modalities are most appropriate given your specific history
- How to coordinate care across psychiatry, therapy, and TMS if multiple approaches are indicated
From there, we build a plan that fits your specific situation — which for many patients includes TMS, therapy, psychiatric care, and the kind of integrated coordination that means everyone involved in your care is working from the same information.
We have better tools now than we’ve ever had. There’s no reason to keep driving the same road and expecting a different destination.
If you’ve been managing depression for years and feel like you’ve exhausted your options, fill out the form below. There’s a good chance you haven’t.
